Novartis (NVS) News Today → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free NVS Stock Alerts $102.57 -0.12 (-0.12%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 7:06 PM | markets.businessinsider.comMaintaining Hold on Novartis Amid Modest Growth Projections and Long-Term CautionMay 16 at 7:15 AM | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 16 at 5:27 AM | globenewswire.comNovartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cashMay 15, 2024 | globenewswire.comNovartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHAMay 14, 2024 | marketbeat.comKLR Investment Advisors LLC Purchases 10,526 Shares of Novartis AG (NYSE:NVS)KLR Investment Advisors LLC grew its position in Novartis AG (NYSE:NVS - Free Report) by 150.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,537 shares of the company's stock after purchasing an additional 10,526 shares during theMay 14, 2024 | fool.com3 Magnificent Stocks That Are Passive Income MachinesMay 12, 2024 | marketbeat.comPrincipal Financial Group Inc. Lowers Position in Novartis AG (NYSE:NVS)Principal Financial Group Inc. decreased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 1.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,508,648 shares of the company's stock after selling 30,617 shares during the period. PrincipaMay 12, 2024 | americanbankingnews.comQ3 2025 EPS Estimates for Novartis AG Lifted by Analyst (NYSE:NVS)May 11, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 195,711 Shares of Novartis AG (NYSE:NVS)Dimensional Fund Advisors LP trimmed its position in Novartis AG (NYSE:NVS - Free Report) by 3.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,078,175 shares of the company's stock after selling 195,711 shares during the period. DimensMay 11, 2024 | marketbeat.comPrincipal Securities Inc. Acquires Shares of 20,149 Novartis AG (NYSE:NVS)Principal Securities Inc. bought a new position in shares of Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 20,149 shares of the company's stock, valued at appMay 10, 2024 | marketwatch.comNovartis Gets FDA Breakthrough Therapy Designation for ScemblixMay 10, 2024 | markets.businessinsider.comNovartis' Scemblix Gets Breakthrough Designation For Chronic CMLMay 10, 2024 | marketbeat.comQ3 2025 EPS Estimates for Novartis AG (NYSE:NVS) Lifted by Zacks ResearchNovartis AG (NYSE:NVS - Free Report) - Research analysts at Zacks Research upped their Q3 2025 earnings estimates for shares of Novartis in a report issued on Tuesday, May 7th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share of $2.12 for the quarter,May 9, 2024 | marketbeat.comForesight Global Investors Inc. Acquires 34,475 Shares of Novartis AG (NYSE:NVS)Foresight Global Investors Inc. boosted its holdings in Novartis AG (NYSE:NVS - Free Report) by 35.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 131,975 shares of the company's stock after buying an adMay 9, 2024 | americanbankingnews.comZacks Research Brokers Increase Earnings Estimates for Novartis AG (NYSE:NVS)May 7, 2024 | businesswire.comCagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive OfficerMay 6, 2024 | marketbeat.comWhy Invest in Biotech Stocks (NVS)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesMay 5, 2024 | fool.com2 Magnificent Dividend Stocks to Hold for the Next DecadeMay 5, 2024 | marketbeat.comInternational Assets Investment Management LLC Has $15.08 Million Stake in Novartis AG (NYSE:NVS)International Assets Investment Management LLC lifted its position in Novartis AG (NYSE:NVS - Free Report) by 6,599.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 149,395 shares of the company's stock after purchasing an additional 147,165May 4, 2024 | marketbeat.comRaymond James & Associates Acquires 11,435 Shares of Novartis AG (NYSE:NVS)Raymond James & Associates increased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 2.2% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 529,840 shares of the company's stock after buying an addiMay 3, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Position Trimmed by Summit Global InvestmentsSummit Global Investments reduced its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 32.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 23,873 shares of the company's stock after selling 11,726 shares during the quarter. SuMay 2, 2024 | finance.yahoo.comNovartis to buy Mariana Oncology in radiopharmaceutical expansionMay 2, 2024 | bloomberg.comNovartis to Buy Mariana Oncology, Paying $1 Billion UpfrontMay 2, 2024 | bizjournals.comNovartis to pay $1B upfront for Watertown startup aiming to improve radiation treatmentMay 2, 2024 | marketwatch.comNovartis to pay up to $1.75 billion for U.S. cancer-focused biotechMay 2, 2024 | businesswire.comMariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat CancerMay 2, 2024 | marketbeat.comNew York State Common Retirement Fund Boosts Holdings in Novartis AG (NYSE:NVS)New York State Common Retirement Fund raised its holdings in Novartis AG (NYSE:NVS - Free Report) by 14.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 95,630 shares of the company's stock afterMay 1, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Sells 9,257 Shares of Novartis AG (NYSE:NVS)Raymond James Financial Services Advisors Inc. decreased its position in Novartis AG (NYSE:NVS - Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 337,957 shares of the company's stock after selling 9,257 shareMay 1, 2024 | finance.yahoo.comNovartis Is Tracking Well Above the IndustryApril 30, 2024 | businesswire.comPeptiDream Announces Expansion of Peptide Discovery Collaboration with NovartisApril 30, 2024 | msn.comNew safety risk for MorphoSys drug could complicate Novartis deal - STAT (update)April 29, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Stock Holdings Lifted by Naviter Wealth LLCNaviter Wealth LLC lifted its position in Novartis AG (NYSE:NVS - Free Report) by 24.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 41,219 shares of the company's stock after acquiring an additional 8,116 shares during the qApril 29, 2024 | reuters.comMorphosys says Novartis takeover progressing as planned for H1 2024April 27, 2024 | marketbeat.comUnique Wealth Strategies LLC Invests $825,000 in Novartis AG (NYSE:NVS)Unique Wealth Strategies LLC bought a new stake in Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 8,170 shares of the company's stock, valued at approximately $825,000.April 26, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Syon Capital LLCSyon Capital LLC lessened its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 13.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,649 shares of the company's stockApril 24, 2024 | finance.yahoo.comCompany News for Apr 24, 2024April 24, 2024 | finance.yahoo.comNovartis AG (NYSE:NVS) Q1 2024 Earnings Call TranscriptApril 24, 2024 | marketbeat.comBMO Capital Markets Boosts Novartis (NYSE:NVS) Price Target to $116.00BMO Capital Markets lifted their price target on Novartis from $114.00 to $116.00 and gave the company a "market perform" rating in a research report on Wednesday.April 24, 2024 | finance.yahoo.comFDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine TumorsApril 24, 2024 | marketbeat.comNovartis AG (NYSE:NVS) Expected to Post Q3 2025 Earnings of $1.98 Per ShareNovartis AG (NYSE:NVS - Free Report) - Analysts at Zacks Research cut their Q3 2025 earnings per share estimates for shares of Novartis in a note issued to investors on Monday, April 22nd. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share of $1.98 for tApril 24, 2024 | marketwatch.comNovartis, Medicines for Malaria Say Treatment for Babies Shows EfficacyApril 24, 2024 | markets.businessinsider.comFDA Approves Novartis' Lutathera For Pediatric Gastroenteropancreatic Neuroendocrine TumorsApril 24, 2024 | globenewswire.comNovartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babiesApril 23, 2024 | msn.comNovartis beats top-line and bottom-line estimates; raises FY24 outlookApril 23, 2024 | fool.comWhy Novartis Stock Topped the Market on TuesdayApril 23, 2024 | seekingalpha.comPolaris, Inc. (PII) Q1 2024 Earnings Call TranscriptApril 23, 2024 | proactiveinvestors.comNovartis raises full-year sales and profit guidance after strong Q1April 23, 2024 | investorplace.comNVS Stock Earnings: Novartis Beats EPS, Beats Revenue for Q1 2024April 23, 2024 | globenewswire.comNovartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumorsApril 23, 2024 | investopedia.comNovartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales Climb Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address POTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos. Click here now to see my urgent election warning. NVS Media Mentions By Week NVS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼0.390.42▲Average Medical News Sentiment NVS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼711▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ABT News AZN News PFE News SNY News ABBV News REGN News VRTX News GSK News BMY News ZTS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
